-
Je něco špatně v tomto záznamu ?
Evolution of mutations in the ftsI gene leading to amino acid substitutions in PBP3 in Haemophilus influenzae strains under the selective pressure of ampicillin and cefuroxime
V. Jakubu, I. Vrbova, I. Bitar, M. Cechova, L. Malisova, H. Zemlickova
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
- MeSH
- ampicilin * farmakologie MeSH
- antibakteriální látky * farmakologie MeSH
- bakteriální proteiny genetika metabolismus MeSH
- cefuroxim * farmakologie MeSH
- Haemophilus influenzae * genetika účinky léků MeSH
- hemofilové infekce mikrobiologie MeSH
- lidé MeSH
- mikrobiální testy citlivosti * MeSH
- molekulární evoluce MeSH
- mutace * MeSH
- proteiny vázající penicilin * genetika metabolismus MeSH
- sekvenování celého genomu MeSH
- selekce (genetika) MeSH
- sériové pasážování MeSH
- substituce aminokyselin * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Aminopenicillins are recommended agents for non-invasive Haemophilus influenzae infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the ftsI gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of H. influenzae strains with the non-enzymatic mechanism of resistance. OBJECTIVES: The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in H. influenzae strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3. METHODS: 30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing. RESULTS: On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin. CONCLUSIONS: Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019125
- 003
- CZ-PrNML
- 005
- 20241231101839.0
- 007
- ta
- 008
- 241015e20240617gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijmm.2024.151626 $2 doi
- 035 __
- $a (PubMed)38954914
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Jakubu, Vladislav $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Prague, Czech Republic; Department of Microbiology, 3rd Faculty of Medicine, Kralovske Vinohrady University Hospital and National Institute of Public Health, Charles University, Ruska 87, 100 00 Prague 10, Prague, Czech Republic
- 245 10
- $a Evolution of mutations in the ftsI gene leading to amino acid substitutions in PBP3 in Haemophilus influenzae strains under the selective pressure of ampicillin and cefuroxime / $c V. Jakubu, I. Vrbova, I. Bitar, M. Cechova, L. Malisova, H. Zemlickova
- 520 9_
- $a BACKGROUND: Aminopenicillins are recommended agents for non-invasive Haemophilus influenzae infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the ftsI gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of H. influenzae strains with the non-enzymatic mechanism of resistance. OBJECTIVES: The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in H. influenzae strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3. METHODS: 30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing. RESULTS: On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin. CONCLUSIONS: Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic.
- 650 12
- $a cefuroxim $x farmakologie $7 D002444
- 650 12
- $a ampicilin $x farmakologie $7 D000667
- 650 12
- $a Haemophilus influenzae $x genetika $x účinky léků $7 D006193
- 650 12
- $a mikrobiální testy citlivosti $7 D008826
- 650 12
- $a proteiny vázající penicilin $x genetika $x metabolismus $7 D046915
- 650 12
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 12
- $a substituce aminokyselin $7 D019943
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a bakteriální proteiny $x genetika $x metabolismus $7 D001426
- 650 _2
- $a hemofilové infekce $x mikrobiologie $7 D006192
- 650 _2
- $a sekvenování celého genomu $7 D000073336
- 650 _2
- $a molekulární evoluce $7 D019143
- 650 _2
- $a selekce (genetika) $7 D012641
- 650 _2
- $a sériové pasážování $7 D012692
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vrbová, Iveta $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Prague, Czech Republic $7 xx0327427
- 700 1_
- $a Bitar, Ibrahim $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1237/65, 301 00, Plzen, Czech Republic
- 700 1_
- $a Čechová, Markéta $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Prague, Czech Republic $7 xx0327426
- 700 1_
- $a Malisova, Lucia $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Prague, Czech Republic; Department of Microbiology, 3rd Faculty of Medicine, Kralovske Vinohrady University Hospital and National Institute of Public Health, Charles University, Ruska 87, 100 00 Prague 10, Prague, Czech Republic
- 700 1_
- $a Zemlickova, Helena $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Prague, Czech Republic; Department of Microbiology, 3rd Faculty of Medicine, Kralovske Vinohrady University Hospital and National Institute of Public Health, Charles University, Ruska 87, 100 00 Prague 10, Prague, Czech Republic. Electronic address: helena.zemlickova@lf3.cuni.cz
- 773 0_
- $w MED00005699 $t International journal of medical microbiology : IJMM $x 1618-0607 $g Roč. 316 (20240617), s. 151626
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38954914 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241231101838 $b ABA008
- 999 __
- $a ok $b bmc $g 2201760 $s 1231098
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 316 $c - $d 151626 $e 20240617 $i 1618-0607 $m International journal of medical microbiology : IJMM $n Int J Med Microbiol $x MED00005699
- LZP __
- $a Pubmed-20241015
